TY - JOUR
T1 - Impact of Brief Quality Improvement Coaching on Adolescent HPV Vaccination Coverage
T2 - A Pragmatic Cluster Randomized Trial
AU - Gilkey, Melissa B.
AU - Heisler-MacKinnon, Jennifer
AU - Boynton, Marcella H.
AU - Calo, William A.
AU - Moss, Jennifer L.
AU - Brewer, Noel T.
N1 - Publisher Copyright:
© 2022 American Association for Cancer Research.
PY - 2023/7/1
Y1 - 2023/7/1
N2 - Background: Health departments in the United States routinely conduct quality improvement (QI) coaching to help primary care providers optimize vaccine delivery. In a prior trial focusing on multiple adolescent vaccines, this light-touch intervention yielded only short-term improvements in HPV vaccination. We sought to evaluate the impact of an enhanced, HPV vaccinespecific QI coaching intervention when delivered in person or virtually. Methods: We partnered with health departments in three states to conduct a pragmatic cluster randomized trial in 2015 to 2016. We randomized 224 primary care clinics to receive no intervention (control), in-person coaching, or virtual coaching. Health department staff delivered the brief (45-60 minute) coaching interventions, including HPV vaccine-specific training with assessment and feedback on clinics' vaccination coverage (i.e., proportion of patients vaccinated). States' immunization information systems provided data to assess coverage change for HPV vaccine initiation (≥1 doses) at 12-month follow-up, among patients ages 11 to 12 (primary outcome) and 13 to 17 (secondary outcome) at baseline. Results: Clinics served 312,227 patients ages 11 to 17. For ages 11 to 12, coverage change for HPV vaccine initiation was higher in the in-person and virtual coaching arms than in the control arm at 12- month follow-up (1.2% and 0.7% point difference, both P < 0.05). For ages 13 to 17, coverage change was higher for virtual coaching than control (1.4% point difference, P < 0.001), but in-person coaching did not yield an intervention effect. Conclusions: Our brief QI coaching intervention produced small long-term improvements in HPV vaccination. Impact: Health departments may benefit from targeting QI coaching to specific vaccines, like HPV vaccine, that need them most.
AB - Background: Health departments in the United States routinely conduct quality improvement (QI) coaching to help primary care providers optimize vaccine delivery. In a prior trial focusing on multiple adolescent vaccines, this light-touch intervention yielded only short-term improvements in HPV vaccination. We sought to evaluate the impact of an enhanced, HPV vaccinespecific QI coaching intervention when delivered in person or virtually. Methods: We partnered with health departments in three states to conduct a pragmatic cluster randomized trial in 2015 to 2016. We randomized 224 primary care clinics to receive no intervention (control), in-person coaching, or virtual coaching. Health department staff delivered the brief (45-60 minute) coaching interventions, including HPV vaccine-specific training with assessment and feedback on clinics' vaccination coverage (i.e., proportion of patients vaccinated). States' immunization information systems provided data to assess coverage change for HPV vaccine initiation (≥1 doses) at 12-month follow-up, among patients ages 11 to 12 (primary outcome) and 13 to 17 (secondary outcome) at baseline. Results: Clinics served 312,227 patients ages 11 to 17. For ages 11 to 12, coverage change for HPV vaccine initiation was higher in the in-person and virtual coaching arms than in the control arm at 12- month follow-up (1.2% and 0.7% point difference, both P < 0.05). For ages 13 to 17, coverage change was higher for virtual coaching than control (1.4% point difference, P < 0.001), but in-person coaching did not yield an intervention effect. Conclusions: Our brief QI coaching intervention produced small long-term improvements in HPV vaccination. Impact: Health departments may benefit from targeting QI coaching to specific vaccines, like HPV vaccine, that need them most.
UR - http://www.scopus.com/inward/record.url?scp=85164245295&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85164245295&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-22-0866
DO - 10.1158/1055-9965.EPI-22-0866
M3 - Article
C2 - 36480272
AN - SCOPUS:85164245295
SN - 1055-9965
VL - 32
SP - 957
EP - 962
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 7
ER -